HD 18 for advanced stages: treatment optimization trial in the first line treatment of advanced stage Hodgkin Lymphoma; treatment stratification by means of FDG-PET
Latest Information Update: 25 Aug 2021
At a glance
- Drugs Rituximab (Primary) ; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Prednisone; Procarbazine; Vincristine
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 11 Nov 2020 Status changed from active, no longer recruiting to completed.
- 30 May 2020 This trial has been completed in Austria, according to the European Clinical Trials Database record.
- 30 Aug 2018 Results published in the Blood.